Jossen Valentin

Jossen Valentin is an Associate Professor at the University of Applied Sciences and Arts Western Switzerland (HES-SO Valais-Wallis), School of Engineering, within the Chemistry and Life Sciences department. His academic work focuses on Life Sciences Engineering, with particular expertise in bioprocessing technologies for cell-based therapies. Valentin maintains an active research program that bridges engineering principles with biological applications, specifically targeting the manufacturing challenges of advanced therapeutic products.

Valentin's research interests center on bioprocess engineering with a strong emphasis on stem cell culture systems, bioreactor technology (particularly single-use systems), and computational fluid dynamics applications in bioprocessing. His work addresses critical challenges in scaling up cell culture processes while maintaining cell quality and functionality. He has made significant contributions to the development of xeno-free and serum-free culture systems for human mesenchymal stem cells, which are essential for clinical applications in regenerative medicine.

Analysis of Valentin's publication record reveals a consistent focus on improving bioprocessing methods for cell therapies, with particular attention to microcarrier-based culture systems, computational modeling of bioreactor environments, and the development of standardized production protocols. His work demonstrates a progression from fundamental fluid dynamics studies toward practical applications in clinical-scale manufacturing, reflecting the maturation of the cell therapy field. The publications span multiple disciplines including bioprocess engineering, regenerative medicine, and pharmaceutical manufacturing, highlighting the interdisciplinary nature of his research.

Valentin's research has significant implications for the commercial production of cell-based therapeutics, addressing key challenges in process scalability, regulatory compliance, and product quality. His work on single-use bioreactor systems and computational modeling provides valuable tools for the biopharmaceutical industry as it transitions from traditional manufacturing approaches to more advanced, flexible production systems capable of meeting the demands of personalized and regenerative medicine.